Reuters Health Report

Click to View in Browser 12/30/2013 Sanofi MS drug suffers setback in key U.S. market PARIS (Reuters) - Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme. High rates of high blood pressure persist in US Southeast NEW YORK (Reuters Health) - One third of U.S. adults have high blood pressure, but in the southeastern part of the country the rate is well over half, according to a new study that finds too little is being done to reverse the problem. Carmat artificial heart patient in good condition: hospital PARIS (Reuters) - French artificial heart maker Carmat's first patient is in a "very satisfactory condition" 12 days after being fitted with the device, the hospital treating him said on Monday. Straumann to cut prices of some dental implants ZURICH (Reuters) - The world's largest dental implant maker, Straumann, will cut the price of its standard titanium implants by around 15 percent next year in Germany, Austria and Switzerland, the firm's chief executive told a Swiss newspaper on Sunday. Small changes in kids' fast food meal cut calories NEW YORK (Reuters Health) - Changes made last year to McDonald's Happy Meals selections for children may be helping kids to cut calories, according to a new study. Strict parenting may reduce teen smoking NEW YORK (Reuters Health) - Parents who set limits are less likely to have kids who smoke, regardless of their ethnic and racial backgrounds, according to a new U.S. study. Lundbeck gets EU marketing approval for Brintellix COPENHAGEN (Reuters) - Danish drugmaker Lundbeck has received marketing authorization from the European Commission for its antidepressant Brintellix following approval in the United States in September, it said on Friday. German state of Hesse threatens to sue Rhoen over particle therapy FRANKFURT (Reuters) - Germany's state of Hesse said on Friday it was preparing to file a suit against Rhoen-Klinikum if the hospitals operator fails to meet a deadline to start offering particle therapy at its Giessen-Marburg hospital. WHO says 4 new Saudi cases of MERS virus, one fatal LONDON (Reuters) - Four more people in Saudi Arabia have been infected with the SARS-like Middle East Respiratory Syndrome (MERS) virus and one of them - an elderly man - has died, the World Health Organisation (WHO) said on Friday. Anxiety linked to stroke risk NEW YORK (Reuters Health) - Men and women with severe symptoms of anxiety may have a higher risk of stroke than their more relaxed counterparts, a new study suggests. Related Video How the zebra got its stripes - scientists reveal all Northern lights bring spectacular Xmas to Lapland The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend